BRCA1 and cancer: Previous research has explored the naming preferences of adults for a cancer-related pathogenic variant, finding ‘faulty gene’ to be the preferred term among cancer patients, community members and men at high-risk of carrying a BRCA1/2 pathogenic variant [25,26].